These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16945746)

  • 21. In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness.
    Hueper K; Zapf A; Skrok J; Pinheiro A; Goldstein TA; Zheng J; Zimmerman SL; Kamel IR; Abraham R; Wacker F; Bluemke DA; Abraham T; Vogel-Claussen J
    PLoS One; 2012; 7(7):e41974. PubMed ID: 22860042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy.
    Calabretta R; Kokomani A; Fumagalli C; Olivotto I; Camici PG; Hacker M; Sciagrà R
    J Nucl Cardiol; 2022 Aug; 29(4):1946-1951. PubMed ID: 35112308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
    Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
    Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathetic denervation is associated with microvascular dysfunction in non-infarcted myocardium in patients with cardiomyopathy.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Wu L; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):788-98. PubMed ID: 25711350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function.
    Soler R; Rodríguez E; Monserrat L; Méndez C; Martínez C
    J Comput Assist Tomogr; 2006; 30(3):412-20. PubMed ID: 16778615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K; Hirano M; Ookubo H; Sasaki K; Katsuyama H; Amino M; Abe Y; Yamashina A
    Magn Reson Imaging; 2004 Feb; 22(2):155-61. PubMed ID: 15010107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study.
    Masci PG; Marinelli M; Piacenti M; Lorenzoni V; Positano V; Lombardi M; L'Abbate A; Neglia D
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):482-90. PubMed ID: 20463209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of regional hypertrophy in hypertrophic cardiomyopathy with ECG triggered nuclear magnetic resonance tomography--comparison with hypertensive patients and persons with healthy hearts].
    Schneider R; Köhler D; Berghöfer G; Paeprer H; Felix R; Thormann I; Schörner W; Schmutzler H
    Z Kardiol; 1985 Mar; 74(3):144-51. PubMed ID: 3158127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy.
    Timmer SA; Lubberink M; Germans T; Götte MJ; ten Berg JM; ten Cate FJ; van Rossum AC; Lammertsma AA; Knaapen P
    J Nucl Cardiol; 2010 Apr; 17(2):264-75. PubMed ID: 20039151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.
    Roldan P; Ravi S; Hodovan J; Belcik JT; Heitner SB; Masri A; Lindner JR
    Cardiovasc Ultrasound; 2022 Sep; 20(1):23. PubMed ID: 36117179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the Choice of Native T
    Kräuter C; Reiter U; Reiter C; Nizhnikava V; Schmidt A; Stollberger R; Fuchsjäger M; Reiter G
    J Magn Reson Imaging; 2021 Mar; 53(3):755-765. PubMed ID: 33034120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations.
    Ganame J; Mertens L; Eidem BW; Claus P; D'hooge J; Havemann LM; McMahon CJ; Elayda MA; Vaughn WK; Towbin JA; Ayres NA; Pignatelli RH
    Eur Heart J; 2007 Dec; 28(23):2886-94. PubMed ID: 17971400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI.
    Amano Y; Takayama M; Fukushima Y; Kitamura M; Kumita S
    Acta Radiol; 2011 Jul; 52(6):613-8. PubMed ID: 21498307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.